BFA
EPZM

BlackRock Fund Advisors’s Epizyme, Inc EPZM Stock Holding History

BlackRock Fund Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$24.4M Buy
2,015,105
+216,376
+12% +$2.26M ﹤0.01% 2070
2016
Q3 		$17.7M Buy
1,798,729
+109,415
+6% +$999K ﹤0.01% 2135
2016
Q2 		$17.3M Sell
1,689,314
-9,202
-0.5% -$103K ﹤0.01% 2108
2016
Q1 		$20.6M Buy
1,698,516
+502,627
+42% +$5.08M ﹤0.01% 1978
2015
Q4 		$19.2M Sell
1,195,889
-82,176
-6% -$1.22M ﹤0.01% 2070
2015
Q3 		$16.4M Buy
1,278,065
+55,334
+5% +$1.12M ﹤0.01% 2114
2015
Q2 		$29.3M Buy
1,222,731
+397,649
+48% +$7.65M 0.01% 1871
2015
Q1 		$15.5M Buy
825,082
+94,042
+13% +$1.94M ﹤0.01% 2202
2014
Q4 		$13.8M Buy
731,040
+42,527
+6% +$993K ﹤0.01% 2266
2014
Q3 		$18.7M Buy
688,513
+13,878
+2% +$431K 0.01% 1996
2014
Q2 		$21M Buy
674,635
+105,568
+19% +$2.49M 0.01% 1991
2014
Q1 		$13M Buy
569,067
+97,947
+21% +$2.97M ﹤0.01% 2241
2013
Q4 		$9.8M Buy
471,120
+318,975
+210% +$9.25M ﹤0.01% 2404
2013
Q3 		$6.09M Buy
152,145
+18,237
+14% +$618K ﹤0.01% 2663
2013
Q2 		$3.77M Buy
+133,908
New +$3.44M ﹤0.01% 2876

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock Fund Advisors's EPZM Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Epizyme, Inc (EPZM) stake by 12% in Q4 2016, buying an estimated $2.26M and bringing the position to 2,015,105 shares worth $24.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2070.

BlackRock Fund Advisors first reported a position in EPZM in Q2 2013 and has held it in 15 quarters since. The position peaked at $29.3M in Q2 2015. 94 funds tracked by Wall St. Rank hold EPZM as of Q4 2016.

  • BlackRock Fund Advisors held 2,015,105 shares of Epizyme, Inc worth $24.4M as of Q4 2016.
  • BlackRock Fund Advisors bought 216,376 Epizyme, Inc shares in Q4 2016, an estimated $2.26M.
  • Epizyme, Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2070 holding.
  • BlackRock Fund Advisors first reported a position in Epizyme, Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Epizyme, Inc position peaked at $29.3M in Q2 2015.
  • 94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.